Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 25, 2026

The "Great Rotation" Out of Tech Is Fading. Here Are the Best Artificial Intelligence (AI) Growth Stocks Poised to Benefit.

View original at finance.yahoo.com
The "Great Rotation" Out of Tech Is Fading. Here Are the Best Artificial Intelligence (AI) Growth Stocks Poised to Benefit. The so-called "Great Rotation" out of tech and artificial intelligence (AI) stocks appears to have been short-lived…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Broadcom projected it would sell $100 billion in AI chips alone in fiscal year 2027

    60% confidence
  • Growth is still the place to be in equities, and right now the biggest growth is coming from AI

    60% confidence
  • Hyperscalers are increasingly turning to Broadcom as they look to become less reliant on Nvidia

    60% confidence
  • The Great Rotation out of tech and AI stocks appears to have been short-lived

    60% confidence
  • The next phase of AI will be more about inference and AI agents rather than model training

    60% confidence
  • AMD's data center CPU business is set to deliver new CPUs designed specifically for agentic AI

    60% confidence
  • AMD's chiplet design packs more memory into its chips, differentiating it in the inference GPU market

    60% confidence
  • AMD is the leader in the data center CPU market

    60% confidence
  • Broadcom is a leader in data center networking with its Tomahawk Ethernet solution and is seeing robust growth in that segment

    60% confidence
  • As agentic AI rises, the CPU-to-GPU ratio in AI data centers is about to get much tighter

    60% confidence
  • Broadcom's projected $100 billion in AI chip revenue for FY2027 is approximately 5 times the total AI revenue it produced in the prior year

    60% confidence

Data points we hold from this source

Anthropic · backlog21 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com